• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4595230)   Today's Articles (0)   Subscriber (49331)
For: Mohammed AQ, Sunkari PK, Srinivas P, Roy AK. Quality by Design in Action 1: Controlling Critical Quality Attributes of an Active Pharmaceutical Ingredient. Org Process Res Dev 2015. [DOI: 10.1021/op500295a] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Number Cited by Other Article(s)
1
Ensuring regulatory compliance by quality by design (QbD) approach to optimize the manufacturing process of API: ferric ammonium citrate as an example. CHEMICAL PAPERS 2022. [DOI: 10.1007/s11696-022-02569-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
2
Development and Validation of RP-UHPLC Method for Quantification of Gliclazide in Bulk and Pharmaceutical Dosage Form Using Quality-by-Design (QbD) Approach: A Shifting Paradigm. Chromatographia 2022. [DOI: 10.1007/s10337-022-04175-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
3
Abe Y, Emori K. Application of a Statistical Approach to Process Development of Futibatinib by Employing Quality-by-Design Principles. Part 1: Identification of Critical Process Parameters for Impurities. Org Process Res Dev 2022. [DOI: 10.1021/acs.oprd.1c00145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
4
Knoll S, Jusner CE, Sagmeister P, Williams JD, Hone CA, Horn M, Kappe CO. Autonomous model-based experimental design for rapid reaction development. REACT CHEM ENG 2022. [DOI: 10.1039/d2re00208f] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
5
Gurumukhi VC, Bari SB. Quantification and Validation of Stability-Indicating RP-HPLC Method for Efavirenz in Bulk and Tablet Dosage Form using Quality by Design (QbD): A Shifting Paradigm. J Chromatogr Sci 2021;60:143-156. [PMID: 34021559 DOI: 10.1093/chromsci/bmab061] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2019] [Indexed: 11/14/2022]
6
Sulbactam pivoxil powder attributes and compatibility study with excipients. FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES 2021. [DOI: 10.1186/s43094-020-00177-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]  Open
7
A Systematic AQbD Approach for Optimization of the Most Influential Experimental Parameters on Analysis of Fish Spoilage-Related Volatile Amines. Foods 2020;9:foods9091321. [PMID: 32961697 PMCID: PMC7555788 DOI: 10.3390/foods9091321] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2020] [Revised: 09/07/2020] [Accepted: 09/16/2020] [Indexed: 11/24/2022]  Open
8
Gurumukhi VC, Bari SB. Fabrication of efavirenz loaded nano-formulation using quality by design (QbD) based approach: Exploring characterizations and in vivo safety. J Drug Deliv Sci Technol 2020. [DOI: 10.1016/j.jddst.2020.101545] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
9
Cole KP. What Elements Contribute to a High-Quality Continuous Processing Submission for OPR&D? Org Process Res Dev 2020. [DOI: 10.1021/acs.oprd.0c00020] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
10
Matji A, Donato N, Gagol A, Morales E, Carvajal L, Serrano DR, Worku ZA, Healy AM, Torrado JJ. Predicting the critical quality attributes of ibuprofen tablets via modelling of process parameters for roller compaction and tabletting. Int J Pharm 2019;565:209-218. [DOI: 10.1016/j.ijpharm.2019.05.011] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2019] [Revised: 04/23/2019] [Accepted: 05/05/2019] [Indexed: 11/25/2022]
11
Barmpalexis P, Karagianni A, Karasavvaides G, Kachrimanis K. Comparison of multi-linear regression, particle swarm optimization artificial neural networks and genetic programming in the development of mini-tablets. Int J Pharm 2018;551:166-176. [PMID: 30227239 DOI: 10.1016/j.ijpharm.2018.09.026] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2018] [Revised: 09/11/2018] [Accepted: 09/12/2018] [Indexed: 11/30/2022]
12
Worku ZA, Kumar D, Gomes JV, He Y, Glennon B, Ramisetty KA, Rasmuson ÅC, O’Connell P, Gallagher KH, Woods T, Shastri NR, Healy AM. Modelling and understanding powder flow properties and compactability of selected active pharmaceutical ingredients, excipients and physical mixtures from critical material properties. Int J Pharm 2017;531:191-204. [DOI: 10.1016/j.ijpharm.2017.08.063] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2017] [Revised: 07/20/2017] [Accepted: 08/05/2017] [Indexed: 10/19/2022]
13
Sato H, Watanabe S, Takeda D, Yano S, Doki N, Yokota M, Shimizu K. Optimization of a Crystallization Process for Orantinib Active Pharmaceutical Ingredient by Design of Experiment To Control Residual Solvent Amount and Particle Size Distribution. Org Process Res Dev 2015. [DOI: 10.1021/acs.oprd.5b00149] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
14
Mohammed AQ, Sunkari PK, Mohammed AB, Srinivas P, Roy AK. Quality by Design in Action 2: Controlling Critical Material Attributes during the Synthesis of an Active Pharmaceutical Ingredient. Org Process Res Dev 2015. [DOI: 10.1021/op500297g] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA